Prognostic Impact of a Body Mass Index Decrease during First Chemotherapy in Patients with Advanced Follicular Lymphoma

OBJECTIVE: Follicular lymphoma (FL) is an indolent B-cell malignancy, usually treated by immunochemotherapy in advanced-stage and high-tumor-burden cases. Although some reports have shown no significant relationship between the pre-treatment body mass index (BMI) and the overall survival (OS) in FL,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Makoto, Harada, Yasuhiko, Kagami, Yoshitoyo, Hiraga, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381350/
https://www.ncbi.nlm.nih.gov/pubmed/35850985
http://dx.doi.org/10.2169/internalmedicine.8838-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381350/
https://www.ncbi.nlm.nih.gov/pubmed/35850985
http://dx.doi.org/10.2169/internalmedicine.8838-21

Ejemplares similares